Ngabonziza, J-C S <br/><br/>
Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda.  [electronic resource] 

 -  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease  03 2020 
 - 329-339 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1815-7920 
<br/><br/><label>Standard No.: </label>10.5588/ijtld.19.0298  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antitubercular Agents--therapeutic use<br/>Delayed Diagnosis<br/>Humans<br/>Microbial Sensitivity Tests<br/>Mycobacterium tuberculosis<br/>Retrospective Studies<br/>Rifampin--therapeutic use<br/>Rwanda--epidemiology<br/>Time-to-Treatment<br/>Tuberculosis, Multidrug-Resistant--diagnosis